Results - Announcements
Laurus Labs Ltd share price ticked higher by 2.11% to Rs 2184.95 after the company's net profit saw a strong growth of 20.65% to Rs 436.74 crore, while revenue from operations improved marginally 8.89% to Rs 2206.37 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, gaining 4.24%. It has improved by 3.87% over last one week and gained upto 0.06% in last one month while the market capitalization of Laurus Labs Ltd has inched up 9.36% and 20.31% in the same period respectively.
Profit before tax (PBT) of Laurus Labs Ltd stood at Rs 591.82 crore in Q3 FY26, jumping 119.41% year-on-year, and rallying 22.95% quarter-on-quarter. EBITDA came in at Rs 737 crore, expanding by 95.93% YoY and surging by 17.20% sequentially.
Total expenses saw a slight increase of 4.73% to Rs 1583.46 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 900.69 crore, advancing by 14.63% YoY, while employee benefits expense was at Rs 265.71 crore, easing 2.71% YoY.
For the TTM ended FY26, revenue from operations jumped by 22.67% to Rs 6812.9 crore, while net profit jumped 151.08% to Rs 889.85 crore, compared to previous TTM. EBITDA soared by 102914% to Rs 1722.76 crore, and PBT witnessed a strong rise of 144.04% to Rs 1181.88 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 1623.5 crore in FY26, as against Rs 601.65 crore in FY25.
Laurus Labs Ltd rallied 127.68% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 13.45% during the same period.